BLFY
FY2027 EPS Estimate
$0.18
FY2027E EPS$0.18

Analyst Sentiment

Wall St. Consensus
Hold
3 analysts·Low coverage
50
Score
0 Buy (0%)3 Hold (100%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
00%
Hold
3100%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$12.00
-9.4%
Consensus
$12.00
-9.4%
Bull
$12.00
-9.4%
12-Month Target Range3 analysts
$12.00$12.00$12.00
Current $13.24Consensus
Current Price
$13.24
Above Consensus
$1.24

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+14.29%
EPS
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027E
Revenue Avg$58M$66M
Low$58M$66M
High$58M$66M
EBITDA Avg$245,962$8M
Low$245,962$8M
High$245,962$8M
EBIT Avg$-3M$4M
Low$-3M$4M
High$-3M$4M
Net Income Avg$-3M$4M
Low$-3M$4M
High$-3M$4M
EPS Avg$-0.15$0.18
Low$-0.15$0.18
High$-0.15$0.18
Analysts (Rev / EPS)1 / 11 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027
Revenue Avg$15M$16M$16M$16M$17M$17M
Low$15M$16M$16M$16M$17M$17M
High$15M$16M$16M$16M$17M$17M
EBITDA Avg$2M$3M$3M$3M$4M$5M
Low$2M$3M$3M$3M$4M$5M
High$2M$3M$3M$3M$4M$5M
EBIT Avg$-196,468$248,693$124,346$497,387$1M$2M
Low$-196,468$248,693$124,346$497,387$1M$2M
High$-196,468$248,693$124,346$497,387$1M$2M
Net Income Avg$-196,468$196,468$98,234$392,936$1M$2M
Low$-196,468$196,468$98,234$392,936$1M$2M
High$-196,468$196,468$98,234$392,936$1M$2M
EPS Avg$-0.01$0.01$0.01$0.02$0.06$0.10
Low$-0.01$0.01$0.01$0.02$0.06$0.10
High$-0.01$0.01$0.01$0.02$0.06$0.10
Analysts (Rev / EPS)1 / 11 / 11 / 11 / 11 / 11 / 1

Earnings Surprises

Recent Analyst Actions

Jul 29, 2024Piper Sandler
Blue Foundry Bancorp (BLFY) PT Raised to $12 at Piper Sandler
Target:$12.00
+7.3%from $11.18
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.